NONOF / Novo Nordisk A/S - SEC Filings, Relazione annuale, dichiarazione di delega

Novo Nordisk A/S
US ˙ OTCPK ˙ DK0062498333

SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Novo Nordisk A/S
Other Listings
AT:NNO2
GB:0QIU 352,65 DKK
DK:NOVO B 365,10 DKK
BG:NOV
MX:NOVOB N
PL:NVO 201,15 PLN
GB:NOVD
GB:NOVOBC
DE:NOV 46,88 €
CH:NOVOB
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista